99Tc-MDP for Thyroid-Associated Ophthalmopathy

Summary

To investigate the efficacy，safety and tolerability of 99Tc-MDP in comparison to Methylprednisolone, in the treatment of participants suffering from active moderate to severe TAO.

Timeline

Start

2017-10-16

Primary completion

2018-12-30

Completion

2019-03-31

Drugs

Indications